Latest Myocardial perfusion imaging Stories
Patients who undergo numerous CT scans over their lifetime may be at increased risk for cancer, according to a study published in the April issue of Radiology.
Acusphere, Inc. (NASDAQ: ACUS) announced that additional analyses from its Phase 3 clinical trials of Imagify(TM) (Perflubutane Polymer Microspheres) for Injectable Suspension were presented today at the annual American Heart Association Scientific Sessions in New Orleans, Louisiana.
MALVERN, Pa., Nov.
By Strauss, H William; Miller, D Douglas; Wittry, Mark D; Cerqueira, Manuel D; Garcia, Ernest V; Iskandrian, Abdulmassi S; Schelbert, Heinrich R; Wackers, Frans J; Balon, Helena R; Lang, Otto; Machac, Josef I.
Bracco Diagnostics Inc., the US-based subsidiary of Bracco Imaging SpA and part of the Bracco Group, and Lantheus Medical Imaging, Inc., both worldwide leaders in diagnostic imaging, announced today that the companies have entered into an agreement for Lantheus to co-promote Bracco's CardioGen-82(R) (Rubidium Rb 82 Generator), a myocardial perfusion Positron Emission Tomography (PET) imaging agent.
To: MEDICAL EDITORS Contact: Beth Hodge, +1-240-429-9983, email@example.com, or Steve Carter, +1-301-802-7100, firstname.lastname@example.org, both of the American Society of Nuclear Cardiology BOSTON, Sept. 13 /PRNewswire-USNewswire/ -- Cardiovascular disease kills more women each year than all cancers combined.
To: MEDICAL EDITORS Contact: Beth Hodge, +1-240-429-9983, email@example.com, or Steve Carter, +1-301-802-7100, firstname.lastname@example.org, both of the American Society of Nuclear Cardiology BOSTON, Sept.
By De Winter, O Van De Veire, N; De Bondt, P; Van De Wiele, C; De Buyzere, M; De Backer, G; Gillebert, T C; Dierckx, R A; De Sutter, J Aim.
QuantRx Biomedical has announced that the company's FluoroPharma has achieved positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging.
BOSTON, July 23 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.